Advanced

The case for neural tissue transplantation as a treatment for Parkinson's disease

Widner, H LU (1999) In Advances in neurology 80. p.9-641
Abstract

Neural tissue grafting can be highly effective and constitutes a potentially curative approach for progressive neurodegenerative disorders such as PD. Virtually all signs and symptoms of PD have been shown to improve after grafting but not necessarily simultaneously in one patient. Several technical aspects require improvement before widespread use of neural tissue implants can be recommended. These include better definition of donor tissue in terms of infectious risks, the need and duration of immunosuppressive treatment, and the minimal amount of tissue needed for definite benefit. Somatotropism within the basal ganglia system (with specific targeted grafts) aimed at relieving certain symptoms need to be elucidated experimentally.... (More)

Neural tissue grafting can be highly effective and constitutes a potentially curative approach for progressive neurodegenerative disorders such as PD. Virtually all signs and symptoms of PD have been shown to improve after grafting but not necessarily simultaneously in one patient. Several technical aspects require improvement before widespread use of neural tissue implants can be recommended. These include better definition of donor tissue in terms of infectious risks, the need and duration of immunosuppressive treatment, and the minimal amount of tissue needed for definite benefit. Somatotropism within the basal ganglia system (with specific targeted grafts) aimed at relieving certain symptoms need to be elucidated experimentally. Interaction with the underlying disease process is also important to consider, and the role of intracerebral grafts in differing patterns of parkinsonism needs to be addressed. Grafting is potentially a very powerful therapeutic approach that may evolve to be the ideal treatment for patients with young-onset disease who, when starting to experience fluctuations, may have a life expectancy of 25 years with the disease. For these patients, grafting is likely to be both effective and long-lasting. For these patients, it is likely to become an efficient and also economically sound treatment for the patients and society. Provided that the transplantation procedure is performed judiciously and with strict adherence to basic principles defined from animal and human experimentation, more patients are likely to benefit from the procedure.

(Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Animals, Clinical Trials as Topic, Fetal Tissue Transplantation, Humans, Nerve Tissue, Parkinson Disease, Treatment Outcome, Journal Article, Review
in
Advances in neurology
volume
80
pages
9 pages
publisher
Lippincott Williams & Wilkins
external identifiers
  • scopus:0032616298
ISSN
0091-3952
language
English
LU publication?
yes
id
c75719d5-f4e0-47e1-97e4-ede415d88bf4
date added to LUP
2017-04-19 18:24:05
date last changed
2017-04-28 11:18:08
@article{c75719d5-f4e0-47e1-97e4-ede415d88bf4,
  abstract     = {<p>Neural tissue grafting can be highly effective and constitutes a potentially curative approach for progressive neurodegenerative disorders such as PD. Virtually all signs and symptoms of PD have been shown to improve after grafting but not necessarily simultaneously in one patient. Several technical aspects require improvement before widespread use of neural tissue implants can be recommended. These include better definition of donor tissue in terms of infectious risks, the need and duration of immunosuppressive treatment, and the minimal amount of tissue needed for definite benefit. Somatotropism within the basal ganglia system (with specific targeted grafts) aimed at relieving certain symptoms need to be elucidated experimentally. Interaction with the underlying disease process is also important to consider, and the role of intracerebral grafts in differing patterns of parkinsonism needs to be addressed. Grafting is potentially a very powerful therapeutic approach that may evolve to be the ideal treatment for patients with young-onset disease who, when starting to experience fluctuations, may have a life expectancy of 25 years with the disease. For these patients, grafting is likely to be both effective and long-lasting. For these patients, it is likely to become an efficient and also economically sound treatment for the patients and society. Provided that the transplantation procedure is performed judiciously and with strict adherence to basic principles defined from animal and human experimentation, more patients are likely to benefit from the procedure.</p>},
  author       = {Widner, H},
  issn         = {0091-3952},
  keyword      = {Animals,Clinical Trials as Topic,Fetal Tissue Transplantation,Humans,Nerve Tissue,Parkinson Disease,Treatment Outcome,Journal Article,Review},
  language     = {eng},
  pages        = {9--641},
  publisher    = {Lippincott Williams & Wilkins},
  series       = {Advances in neurology},
  title        = {The case for neural tissue transplantation as a treatment for Parkinson's disease},
  volume       = {80},
  year         = {1999},
}